H.R. 7035
Referred to CommitteeBiologics Market Transparency Act of 2022
Introduced 3/9/2022•117th Congress•House
Latest Action
Referred to the Subcommittee on Health.
3/10/2022 • House
Summary
Biologics Market Transparency Act of 2022
This bill requires biologics manufacturers to notify the Food and Drug Administration in advance of withdrawing a product from sale.
Introduced in House • 3/9/2022
Enter your district to see how this bill affects your community
Topics & Subjects
Policy Area: Health
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (2)
Party Breakdown
1
Democrats
1
Republicans
0
Independents
Sponsor
R[
Cosponsors (1)
R[
Bill Journey
Originated in the House
Introduced
March 9, 2022
Referred to the House Committee on Energy and Commerce.
Committee Review
Floor Debate
Passed Chamber
Other Chamber
President
Enacted into Law
Text Versions (1)
Introduced in House3/9/2022